» Articles » PMID: 26230090

Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells

Overview
Journal PLoS One
Date 2015 Aug 1
PMID 26230090
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Withaferin A (WA), a major bioactive component of the Indian herb Withania somnifera, induces cell death (apoptosis/necrosis) in multiple types of tumor cells, but the molecular mechanism underlying this cytotoxicity remains elusive. We report here that 2 μM WA induced cell death selectively in androgen-insensitive PC-3 and DU-145 prostate adenocarcinoma cells, whereas its toxicity was less severe in androgen-sensitive LNCaP prostate adenocarcinoma cells and normal human fibroblasts (TIG-1 and KD). WA also killed PC-3 cells in spheroid-forming medium. DNA microarray analysis revealed that WA significantly increased mRNA levels of c-Fos and 11 heat-shock proteins (HSPs) in PC-3 and DU-145, but not in LNCaP and TIG-1. Western analysis revealed increased expression of c-Fos and reduced expression of the anti-apoptotic protein c-FLIP(L). Expression of HSPs such as HSPA6 and Hsp70 was conspicuously elevated; however, because siRNA-mediated depletion of HSF-1, an HSP-inducing transcription factor, reduced PC-3 cell viability, it is likely that these heat-shock genes were involved in protecting against cell death. Moreover, WA induced generation of reactive oxygen species (ROS) in PC-3 and DU-145, but not in normal fibroblasts. Immunocytochemistry and immuno-electron microscopy revealed that WA disrupted the vimentin cytoskeleton, possibly inducing the ROS generation, c-Fos expression and c-FLIP(L) suppression. These observations suggest that multiple events followed by disruption of the vimentin cytoskeleton play pivotal roles in WA-mediated cell death.

Citing Articles

Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers.

Cao P, Dominic A, Lujan F, Senthilkumar S, Bhattacharya P, Frigo D Nat Rev Urol. 2024; 21(10):615-637.

PMID: 38627553 DOI: 10.1038/s41585-024-00869-9.


Withaferin A and Celastrol Overwhelm Proteostasis.

Vilaboa N, Voellmy R Int J Mol Sci. 2024; 25(1).

PMID: 38203539 PMC: 10779417. DOI: 10.3390/ijms25010367.


Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms.

Xing Z, Su A, Mi L, Zhang Y, He T, Qiu Y Drug Des Devel Ther. 2023; 17:2909-2929.

PMID: 37753228 PMC: 10519218. DOI: 10.2147/DDDT.S422512.


Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant (L.) Dunal.

Kumar S, Mathew S, Aharwal R, Tulli H, Mohan C, Sethi G Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259311 PMC: 9966696. DOI: 10.3390/ph16020160.


The Therapeutic Effects of Withaferin A against Cancer: Overview and Updates.

Abeesh P, Guruvayoorappan C Curr Mol Med. 2023; 24(4):404-418.

PMID: 37076466 DOI: 10.2174/1566524023666230418094708.


References
1.
Liu B, Du Z, Zong Z, Li C, Li N, Zhang Q . BAG3-dependent noncanonical autophagy induced by proteasome inhibition in HepG2 cells. Autophagy. 2013; 9(6):905-16. PMC: 3672299. DOI: 10.4161/auto.24292. View

2.
Gamerdinger M, Kaya A, Wolfrum U, Clement A, Behl C . BAG3 mediates chaperone-based aggresome-targeting and selective autophagy of misfolded proteins. EMBO Rep. 2011; 12(2):149-56. PMC: 3049430. DOI: 10.1038/embor.2010.203. View

3.
Chen S, Chang Y, Nieh S, Liu C, Yang C, Lin Y . Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties. PLoS One. 2012; 7(2):e31864. PMC: 3281010. DOI: 10.1371/journal.pone.0031864. View

4.
Ciocca D, Arrigo A, Calderwood S . Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update. Arch Toxicol. 2012; 87(1):19-48. PMC: 3905791. DOI: 10.1007/s00204-012-0918-z. View

5.
Widodo N, Priyandoko D, Shah N, Wadhwa R, Kaul S . Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling. PLoS One. 2010; 5(10):e13536. PMC: 2958829. DOI: 10.1371/journal.pone.0013536. View